You are viewing an incomplete version of our website. Please click to reload the website as full version.

IMP3, U3 Small Nucleolar Ribonucleoprotein, Homolog (Yeast) (IMP3) (AA 156-184), (C-Term) antibody

Details for Product No. ABIN653856, Supplier: Login to see
Antigen
  • zgc:56526
  • BRMS2
  • C15orf12
  • MRPS4
  • RGD1306825
  • 1190002L16Rik
  • AI256594
  • 2610101N11Rik
  • AA522010
  • AL022933
  • AU045931
  • IMP-3
  • IMP3
  • Koc13
  • Neilsen
  • mimp3
Epitope
AA 156-184, C-Term
16
15
6
2
1
1
1
Reactivity
Human, Mouse (Murine)
58
25
23
3
3
2
Host
Rabbit
42
14
2
Clonality (Clone)
Polyclonal ()
Conjugate
Un-conjugated
4
4
4
3
3
3
1
1
1
1
1
1
1
1
1
Application
Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
38
25
16
15
11
6
2
2
1
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Immunogen This IMP3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 156-184 AA from the C-terminal region of human IMP3.
Clone RB24885
Isotype Ig
Specificity This IMP3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 155~184 amino acids from the C-terminal region of human IMP3.
Purification This antibody is purified through a protein A column, followed by peptide affinity purification.
Alternative Name IMP3 (IMP3 Antibody Abstract)
Background This gene encodes the human homolog of the yeast Imp3 protein. The protein localizes to the nucleoli and interacts with the U3 snoRNP complex. The protein contains an S4 domain.
Synonyms: BRMS2, U3 small nucleolar ribonucleoprotein protein IMP3, U3 snoRNP protein IMP3,MRPS4, C15orf12, IMP3
Molecular Weight 21850 DA
Gene ID 55272
UniProt Q9NV31
Research Area Translation Factors, Transcription Factors, Chromatin, Signaling, Cell Structure
Pathways
Application Notes WB = 1:1000, IHC (p) = 1:50-100, FACS = 1:10-50
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer PBS with 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date 6 months
Supplier Images
Western Blotting (WB) image for anti-IMP3, U3 Small Nucleolar Ribonucleoprotein, Homolog (Yeast) (IMP3) (AA 156-184), (C-Term) antibody (ABIN653856) Western blot analysis of IMP3 Antibody (C-term) (ABIN653856) in Hela cell line lysate...
Immunohistochemistry (IHC) image for anti-IMP3, U3 Small Nucleolar Ribonucleoprotein, Homolog (Yeast) (IMP3) (AA 156-184), (C-Term) antibody (ABIN653856) IMP3 Antibody (C-term) (ABIN653856) IHC analysis in formalin fixed and paraffin embed...
Flow Cytometry (FACS) image for anti-IMP3, U3 Small Nucleolar Ribonucleoprotein, Homolog (Yeast) (IMP3) (AA 156-184), (C-Term) antibody (ABIN653856) IMP3 Antibody (C-term) (ABIN653856) flow cytometric analysis of Hela cells (right his...
Background publications Walter, Prasad, Lu et al.: "IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype." in: Human pathology, Vol. 40, Issue 11, pp. 1528-33, 2009 (PubMed).

Li, Yan, Tang et al.: "IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis." in: Annals of surgical oncology, Vol. 16, Issue 12, pp. 3499-506, 2010 (PubMed).

Noske, Faggad, Wirtz et al.: "IMP3 expression in human ovarian cancer is associated with improved survival." in: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, Vol. 28, Issue 3, pp. 203-10, 2009 (PubMed).

Riener, Fritzsche, Clavien et al.: "IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas." in: Human pathology, Vol. 40, Issue 10, pp. 1377-83, 2009 (PubMed).